Not Signed In - Ranbaxy Granted Final FDA Approval To Market Simvastatin 5, 10, 20 And 40 Mg Tablets
Sat, 23 Dec 2006 08:00 AM EST
... Ranbaxy Laboratories Limited (RLL), announced today that the Company has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg and 40 mg in the U.S. [click link for full article] ...
Related Topics
- Sarin
- Urea skin cream, gel, lotion or ointment
- Coenzyme Q-10
- Amlodipine and Benazepril
- Estradiol Injection
- Research
- Simvastatin
- International Classification of Diseases
- Pantoprazole
- Mammography
- Ethinyl Estradiol and Norethindrone (Oral Contraceptive)
- Pancrelipase
- Olmesartan
- Carbinoxamine and Pseudoephedrine Tablets
- Cerivastatin - Withdrawn From The Market
- Vaccine Testing & Approval
- Potassium Chloride Oral
- Sulfacetamide Ophthalmic
- Sanctura
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
email this page
print this page
bookmark this page
feedback on this page
